Oppenheimer Analyst Recommendations & Stock Picks (NYSE:OPY)

Name: Community Performance Rating
Item: Oppenheimer
Rating: 3.1
Author: MarketBeat

→ The new financial threat that could wipe out millions… (From InvestorPlace) (Ad)

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Oppenheimer. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Oppenheimer.

Company	Current Price	Rating Date	Action	Brokerage	Analyst	Rating	Price Target	Impact on Price	Details
CRBP Corbus Pharmaceuticals	$42.39 +6.6%	5/8/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$58.00 -> $60.00	Low	View details for Oppenheimer rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 5/8/2024
SAR Saratoga Investment	$22.88 -2.5%	5/8/2024	Downgraded by	Oppenheimer	-	Outperform -> Market Perform	$24.00 -> $23.00	Low	View details for Oppenheimer rating of Saratoga Investment (NYSE:SAR) on 5/8/2024
PTON Peloton Interactive	$3.94 -3.7%	5/7/2024	Reiterated by	Oppenheimer	-	Outperform		Low	View details for Oppenheimer rating of Peloton Interactive (NASDAQ:PTON) on 5/7/2024
FRPT Freshpet	$119.21 -1.2%	5/7/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$120.00 -> $135.00	Low	View details for Oppenheimer rating of Freshpet (NASDAQ:FRPT) on 5/7/2024
RXST RxSight	$60.66 -2.5%	5/7/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$61.00 -> $72.00	Low	View details for Oppenheimer rating of RxSight (NASDAQ:RXST) on 5/7/2024
ULTA Ulta Beauty	$388.48 -1.3%	5/7/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$500.00 -> $475.00	Low	View details for Oppenheimer rating of Ulta Beauty (NASDAQ:ULTA) on 5/7/2024
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
PLRX Pliant Therapeutics	$13.41 -2.8%	5/7/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$47.00 -> $48.00	Low	View details for Oppenheimer rating of Pliant Therapeutics (NASDAQ:PLRX) on 5/7/2024
CRVS Corvus Pharmaceuticals	$1.96 +16.7%	5/7/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$7.00 -> $8.00	Low	View details for Oppenheimer rating of Corvus Pharmaceuticals (NASDAQ:CRVS) on 5/7/2024
BOWL Bowlero	$11.30 +0.3%	5/7/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$18.00 -> $15.00	Low	View details for Oppenheimer rating of Bowlero (NYSE:BOWL) on 5/7/2024
ZETA Zeta Global	$15.57 +1.2%	5/7/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$14.00 -> $18.00	Low	View details for Oppenheimer rating of Zeta Global (NASDAQ:ZETA) on 5/7/2024
IART Integra LifeSciences	$24.91 -0.7%	5/7/2024	Downgraded by	Oppenheimer	-	Outperform -> Market Perform		Low	View details for Oppenheimer rating of Integra LifeSciences (NASDAQ:IART) on 5/7/2024
WSC WillScot Mobile Mini	$39.34 +0.4%	5/6/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$60.00 -> $53.00	Low	View details for Oppenheimer rating of WillScot Mobile Mini (NASDAQ:WSC) on 5/6/2024
ACAD ACADIA Pharmaceuticals	$17.13 -0.7%	5/6/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform	$19.00 -> $19.00	Low	View details for Oppenheimer rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 5/6/2024
ALDX Aldeyra Therapeutics	$4.07 -2.4%	5/6/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$10.00 -> $10.00	Low	View details for Oppenheimer rating of Aldeyra Therapeutics (NASDAQ:ALDX) on 5/6/2024
DYN Dyne Therapeutics	$25.69 +0.2%	5/6/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$47.00 -> $47.00	Low	View details for Oppenheimer rating of Dyne Therapeutics (NASDAQ:DYN) on 5/6/2024
RLAY Relay Therapeutics	$6.51 -3.4%	5/6/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$33.00 -> $25.00	Low	View details for Oppenheimer rating of Relay Therapeutics (NASDAQ:RLAY) on 5/6/2024
ENSG The Ensign Group	$116.09 -1.6%	5/6/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$130.00 -> $135.00	Low	View details for Oppenheimer rating of The Ensign Group (NASDAQ:ENSG) on 5/6/2024
TRMB Trimble	$56.54 -0.8%	5/6/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$72.00 -> $72.00	Low	View details for Oppenheimer rating of Trimble (NASDAQ:TRMB) on 5/6/2024
PACS PACS Group	$24.67 -1.3%	5/6/2024	Initiated by	Oppenheimer	-	Outperform	$31.00	Low	View details for Oppenheimer rating of PACS Group (NYSE:PACS) on 5/6/2024
AGCO AGCO	$113.93 -2.7%	5/3/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$154.00 -> $145.00	Low	View details for Oppenheimer rating of AGCO (NYSE:AGCO) on 5/3/2024
APTV Aptiv	$83.20 +0.2%	5/3/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$148.00 -> $145.00	Low	View details for Oppenheimer rating of Aptiv (NYSE:APTV) on 5/3/2024
BWA BorgWarner	$37.51 +1.9%	5/3/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$39.00 -> $40.00	Low	View details for Oppenheimer rating of BorgWarner (NYSE:BWA) on 5/3/2024
CI The Cigna Group	$347.35 +0.2%	5/3/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$370.00 -> $400.00	Low	View details for Oppenheimer rating of The Cigna Group (NYSE:CI) on 5/3/2024
NET Cloudflare	$72.45 -2.3%	5/3/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$122.00 -> $110.00	Low	View details for Oppenheimer rating of Cloudflare (NYSE:NET) on 5/3/2024
COIN Coinbase Global	$211.20 -1.5%	5/3/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$276.00 -> $282.00	Low	View details for Oppenheimer rating of Coinbase Global (NASDAQ:COIN) on 5/3/2024
CTVA Corteva	$56.82 -1.2%	5/3/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$67.00 -> $69.00	Low	View details for Oppenheimer rating of Corteva (NYSE:CTVA) on 5/3/2024
THG The Hanover Insurance Group	$135.47 +0.3%	5/3/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$150.00 -> $165.00	Low	View details for Oppenheimer rating of The Hanover Insurance Group (NYSE:THG) on 5/3/2024
ITRI Itron	$109.06 +0.7%	5/3/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$100.00 -> $110.00	Low	View details for Oppenheimer rating of Itron (NASDAQ:ITRI) on 5/3/2024
KYMR Kymera Therapeutics	$38.50 +0.2%	5/3/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$53.00 -> $52.00	Low	View details for Oppenheimer rating of Kymera Therapeutics (NASDAQ:KYMR) on 5/3/2024
MRNA Moderna	$121.89 +0.7%	5/3/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$142.00 -> $163.00	Low	View details for Oppenheimer rating of Moderna (NASDAQ:MRNA) on 5/3/2024
SPXC SPX Technologies	$133.92 -1.6%	5/3/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$134.00 -> $140.00	Low	View details for Oppenheimer rating of SPX Technologies (NYSE:SPXC) on 5/3/2024
SPT Sprout Social	$26.90 -0.7%	5/3/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$76.00 -> $43.00	Low	View details for Oppenheimer rating of Sprout Social (NASDAQ:SPT) on 5/3/2024
WCC WESCO International	$173.68 -3.8%	5/3/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$190.00 -> $200.00	Low	View details for Oppenheimer rating of WESCO International (NYSE:WCC) on 5/3/2024
XYL Xylem	$141.20 +0.8%	5/3/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$142.00 -> $147.00	Low	View details for Oppenheimer rating of Xylem (NYSE:XYL) on 5/3/2024
ZBH Zimmer Biomet	$120.85 -0.5%	5/3/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$150.00 -> $155.00	Low	View details for Oppenheimer rating of Zimmer Biomet (NYSE:ZBH) on 5/3/2024
ARCC Ares Capital	$20.78 -0.1%	5/2/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$21.00 -> $22.00	Low	View details for Oppenheimer rating of Ares Capital (NASDAQ:ARCC) on 5/2/2024
TCPC BlackRock TCP Capital	$10.52 +0.7%	5/2/2024	Target Lowered by	Oppenheimer	-	Market Perform -> Market Perform	$11.00 -> $10.00	Low	View details for Oppenheimer rating of BlackRock TCP Capital (NASDAQ:TCPC) on 5/2/2024
CG The Carlyle Group	$41.48 -1.2%	5/2/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$74.00 -> $68.00	Low	View details for Oppenheimer rating of The Carlyle Group (NASDAQ:CG) on 5/2/2024
FSLR First Solar	$190.72 -2.0%	5/2/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$269.00 -> $271.00	Low	View details for Oppenheimer rating of First Solar (NASDAQ:FSLR) on 5/2/2024
GNRC Generac	$137.16 +0.5%	5/2/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$140.00 -> $145.00	Low	View details for Oppenheimer rating of Generac (NYSE:GNRC) on 5/2/2024
BREAKING – Pentagon to Spend $20 Billion on “Distributed AI” (Ad) BREAKING - Pentagon to Spend $20 Billion on "Distributed AI" The U.S. Space Force calls it a "game changer." And one tiny firm is poised to win the contract to build it. Discover the name and ticker of this $2 stock here >>>
NGVT Ingevity	$54.00 +0.5%	5/2/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$50.00 -> $58.00	Low	View details for Oppenheimer rating of Ingevity (NYSE:NGVT) on 5/2/2024
INTA Intapp	$36.15 +9.0%	5/2/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$50.00 -> $42.00	Low	View details for Oppenheimer rating of Intapp (NASDAQ:INTA) on 5/2/2024
JCI Johnson Controls International	$65.24 +1.2%	5/2/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$71.00 -> $70.00	Low	View details for Oppenheimer rating of Johnson Controls International (NYSE:JCI) on 5/2/2024
NBIX Neurocrine Biosciences	$139.02 -2.9%	5/2/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$200.00 -> $216.00	Low	View details for Oppenheimer rating of Neurocrine Biosciences (NASDAQ:NBIX) on 5/2/2024
RSI Rush Street Interactive	$8.34 -0.5%	5/2/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$9.00 -> $10.00	Low	View details for Oppenheimer rating of Rush Street Interactive (NYSE:RSI) on 5/2/2024
UTHR United Therapeutics	$261.09 -1.9%	5/2/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$375.00 -> $400.00	Low	View details for Oppenheimer rating of United Therapeutics (NASDAQ:UTHR) on 5/2/2024
FRSH Freshworks	$13.82 -3.1%	5/2/2024	Downgraded by	Oppenheimer	-	Outperform -> Market Perform		Low	View details for Oppenheimer rating of Freshworks (NASDAQ:FRSH) on 5/2/2024
NXPI NXP Semiconductors	$260.21 +0.6%	5/1/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$250.00 -> $295.00	Low	View details for Oppenheimer rating of NXP Semiconductors (NASDAQ:NXPI) on 5/1/2024
RSG Republic Services	$187.33 -0.7%	5/1/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$202.00 -> $204.00	Low	View details for Oppenheimer rating of Republic Services (NYSE:RSG) on 5/1/2024
DAN Dana	$13.61 +1.6%	5/1/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$17.00 -> $18.00	Low	View details for Oppenheimer rating of Dana (NYSE:DAN) on 5/1/2024
DENN Denny's	$8.15 +2.0%	5/1/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$12.00 -> $11.00	Low	View details for Oppenheimer rating of Denny’s (NASDAQ:DENN) on 5/1/2024
TREE LendingTree	$47.81 -2.3%	5/1/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$45.00 -> $55.00	Low	View details for Oppenheimer rating of LendingTree (NASDAQ:TREE) on 5/1/2024
AMZN Amazon.com	$188.00 -0.4%	5/1/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$210.00 -> $220.00	Low	View details for Oppenheimer rating of Amazon.com (NASDAQ:AMZN) on 5/1/2024
TMDX TransMedics Group	$127.22 0.0%	5/1/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$105.00 -> $125.00	Low	View details for Oppenheimer rating of TransMedics Group (NASDAQ:TMDX) on 5/1/2024
LOVE Lovesac	$23.92 -0.1%	5/1/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$60.00 -> $35.00	Low	View details for Oppenheimer rating of Lovesac (NASDAQ:LOVE) on 5/1/2024
DPZ Domino's Pizza	$516.67 -0.1%	4/30/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$530.00 -> $580.00	Low	View details for Oppenheimer rating of Domino’s Pizza (NYSE:DPZ) on 4/30/2024
GS The Goldman Sachs Group	$446.95 +0.7%	4/30/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$479.00 -> $517.00	Low	View details for Oppenheimer rating of The Goldman Sachs Group (NYSE:GS) on 4/30/2024
JEF Jefferies Financial Group	$45.84 +0.4%	4/30/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$54.00 -> $56.00	Low	View details for Oppenheimer rating of Jefferies Financial Group (NYSE:JEF) on 4/30/2024
MS Morgan Stanley	$95.64 -0.2%	4/30/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$101.00 -> $105.00	Low	View details for Oppenheimer rating of Morgan Stanley (NYSE:MS) on 4/30/2024
BAC Bank of America	$37.71 -0.3%	4/30/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$45.00 -> $46.00	Low	View details for Oppenheimer rating of Bank of America (NYSE:BAC) on 4/30/2024
C Citigroup	$62.75 +1.2%	4/30/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$87.00 -> $86.00	Low	View details for Oppenheimer rating of Citigroup (NYSE:C) on 4/30/2024
CNC Centene	$75.85 -0.1%	4/29/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$110.00 -> $110.00	Low	View details for Oppenheimer rating of Centene (NYSE:CNC) on 4/29/2024
EXPE Expedia Group	$111.54 -1.2%	4/29/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$175.00 -> $175.00	Low	View details for Oppenheimer rating of Expedia Group (NASDAQ:EXPE) on 4/29/2024
ROP Roper Technologies	$521.05 +0.2%	4/29/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$650.00 -> $650.00	Low	View details for Oppenheimer rating of Roper Technologies (NYSE:ROP) on 4/29/2024
SFM Sprouts Farmers Market	$74.66 -0.1%	4/29/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Sprouts Farmers Market (NASDAQ:SFM) on 4/29/2024
UBER Uber Technologies	$66.40 -5.7%	4/29/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$90.00	Low	View details for Oppenheimer rating of Uber Technologies (NYSE:UBER) on 4/29/2024
URI United Rentals	$677.84 +0.5%	4/29/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of United Rentals (NYSE:URI) on 4/29/2024
WT WisdomTree	$9.38 +2.0%	4/29/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$11.00 -> $11.00	Low	View details for Oppenheimer rating of WisdomTree (NYSE:WT) on 4/29/2024
LECO Lincoln Electric	$229.46 +0.3%	4/29/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Lincoln Electric (NASDAQ:LECO) on 4/29/2024
BIIB Biogen	$219.72 +0.4%	4/29/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$270.00 -> $270.00	Low	View details for Oppenheimer rating of Biogen (NASDAQ:BIIB) on 4/29/2024
DASH DoorDash	$113.02 -2.2%	4/29/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$140.00 -> $150.00	Low	View details for Oppenheimer rating of DoorDash (NASDAQ:DASH) on 4/29/2024
ETSY Etsy	$62.57 -0.3%	4/29/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$95.00 -> $80.00	Low	View details for Oppenheimer rating of Etsy (NASDAQ:ETSY) on 4/29/2024
HCA HCA Healthcare	$309.42 -1.6%	4/29/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$330.00 -> $345.00	Low	View details for Oppenheimer rating of HCA Healthcare (NYSE:HCA) on 4/29/2024
CART Maplebear	$37.48 -0.1%	4/29/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$36.00 -> $48.00	Low	View details for Oppenheimer rating of Maplebear (NASDAQ:CART) on 4/29/2024
OSIS OSI Systems	$134.26 -0.4%	4/29/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$157.00 -> $160.00	Low	View details for Oppenheimer rating of OSI Systems (NASDAQ:OSIS) on 4/29/2024
POOL Pool	$365.82 -1.8%	4/29/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$436.00 -> $416.00	Low	View details for Oppenheimer rating of Pool (NASDAQ:POOL) on 4/29/2024
GOOGL Alphabet	$169.38 -1.1%	4/26/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$185.00 -> $205.00	Low	View details for Oppenheimer rating of Alphabet (NASDAQ:GOOGL) on 4/26/2024
TEAM Atlassian	$178.52 -3.0%	4/26/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$300.00 -> $250.00	Low	View details for Oppenheimer rating of Atlassian (NASDAQ:TEAM) on 4/26/2024
CSL Carlisle Companies	$408.49 +0.7%	4/26/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$412.00 -> $430.00	Low	View details for Oppenheimer rating of Carlisle Companies (NYSE:CSL) on 4/26/2024
CARR Carrier Global	$64.31 +0.1%	4/26/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$63.00 -> $64.00	Low	View details for Oppenheimer rating of Carrier Global (NYSE:CARR) on 4/26/2024
DOV Dover	$183.75 +1.1%	4/26/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$187.00 -> $197.00	Low	View details for Oppenheimer rating of Dover (NYSE:DOV) on 4/26/2024
RMD ResMed	$212.88 -1.5%	4/26/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$205.00 -> $200.00	Low	View details for Oppenheimer rating of ResMed (NYSE:RMD) on 4/26/2024
SPGI S&P Global	$429.21 +0.2%	4/26/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$480.00 -> $482.00	Low	View details for Oppenheimer rating of S&P Global (NYSE:SPGI) on 4/26/2024
TDOC Teladoc Health	$12.20 -5.3%	4/26/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$26.00 -> $21.00	Low	View details for Oppenheimer rating of Teladoc Health (NYSE:TDOC) on 4/26/2024
TPH Tri Pointe Homes	$39.47 -0.4%	4/26/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$41.00 -> $46.00	Low	View details for Oppenheimer rating of Tri Pointe Homes (NYSE:TPH) on 4/26/2024
WM Waste Management	$210.00 -0.2%	4/26/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$221.00 -> $228.00	Low	View details for Oppenheimer rating of Waste Management (NYSE:WM) on 4/26/2024
TYL Tyler Technologies	$481.02 -0.1%	4/26/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$480.00 -> $500.00	Low	View details for Oppenheimer rating of Tyler Technologies (NYSE:TYL) on 4/26/2024
VRT Vertiv	$97.68 +2.9%	4/25/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$96.00 -> $98.00	Low	View details for Oppenheimer rating of Vertiv (NYSE:VRT) on 4/25/2024
CMG Chipotle Mexican Grill	$3,183.25 -0.3%	4/25/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$2,825.00 -> $3,300.00	Low	View details for Oppenheimer rating of Chipotle Mexican Grill (NYSE:CMG) on 4/25/2024
CYH Community Health Systems	$3.39 +0.6%	4/25/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$5.50 -> $4.50	Low	View details for Oppenheimer rating of Community Health Systems (NYSE:CYH) on 4/25/2024
Fidelity, Bezos, Goldman Bet Big on Tiny Biotech (Ad) Are you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs. Don't miss out on the "next Ozempic" >>>
HUM Humana	$324.14 -0.2%	4/25/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$415.00 -> $370.00	Low	View details for Oppenheimer rating of Humana (NYSE:HUM) on 4/25/2024
META Meta Platforms	$472.60 +0.9%	4/25/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$585.00 -> $500.00	N/A	View details for Oppenheimer rating of Meta Platforms (NASDAQ:META) on 4/25/2024
ENPH Enphase Energy	$112.36 -2.2%	4/24/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$133.00 -> $134.00	Low	View details for Oppenheimer rating of Enphase Energy (NASDAQ:ENPH) on 4/24/2024
INCY Incyte	$53.51 -1.6%	4/24/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$92.00 -> $84.00	Low	View details for Oppenheimer rating of Incyte (NASDAQ:INCY) on 4/24/2024
NBIX Neurocrine Biosciences	$139.02 -2.9%	4/24/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$200.00 -> $200.00	Low	View details for Oppenheimer rating of Neurocrine Biosciences (NASDAQ:NBIX) on 4/24/2024
NEP NextEra Energy Partners	$30.13 0.0%	4/24/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of NextEra Energy Partners (NYSE:NEP) on 4/24/2024
PNR Pentair	$83.36 +0.4%	4/24/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$88.00 -> $90.00	Low	View details for Oppenheimer rating of Pentair (NYSE:PNR) on 4/24/2024
PHM PulteGroup	$115.79 -1.0%	4/24/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$138.00 -> $143.00	Low	View details for Oppenheimer rating of PulteGroup (NYSE:PHM) on 4/24/2024
TSLA Tesla	$174.72 -1.7%	4/24/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Tesla (NASDAQ:TSLA) on 4/24/2024
TXN Texas Instruments	$183.95 +0.7%	4/24/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Texas Instruments (NASDAQ:TXN) on 4/24/2024
UPS United Parcel Service	$147.77 +0.5%	4/24/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$153.00 -> $157.00	Low	View details for Oppenheimer rating of United Parcel Service (NYSE:UPS) on 4/24/2024
V Visa	$277.19 +0.3%	4/24/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$297.00 -> $299.00	Low	View details for Oppenheimer rating of Visa (NYSE:V) on 4/24/2024
MSCI MSCI	$470.75 -0.1%	4/24/2024	Reiterated by	Oppenheimer	-	Outperform -> Market Perform		Low	View details for Oppenheimer rating of MSCI (NYSE:MSCI) on 4/24/2024
EA Electronic Arts	$125.24 -3.8%	4/23/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$150.00 -> $150.00	Low	View details for Oppenheimer rating of Electronic Arts (NASDAQ:EA) on 4/23/2024
GANX Gain Therapeutics	$2.68 -7.6%	4/23/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$9.00	Low	View details for Oppenheimer rating of Gain Therapeutics (NASDAQ:GANX) on 4/23/2024
TTWO Take-Two Interactive Software	$145.97 -1.6%	4/23/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$185.00	Low	View details for Oppenheimer rating of Take-Two Interactive Software (NASDAQ:TTWO) on 4/23/2024
VZ Verizon Communications	$39.48 +0.4%	4/23/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$48.00 -> $48.00	Low	View details for Oppenheimer rating of Verizon Communications (NYSE:VZ) on 4/23/2024
CHD Church & Dwight	$106.78 -0.1%	4/23/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$110.00 -> $120.00	Low	View details for Oppenheimer rating of Church & Dwight (NYSE:CHD) on 4/23/2024
ATRC AtriCure	$20.69 -5.4%	4/23/2024	Upgraded by	Oppenheimer	-	Market Perform -> Outperform	$32.00	Low	View details for Oppenheimer rating of AtriCure (NASDAQ:ATRC) on 4/23/2024
TARA Protara Therapeutics	$2.83 -1.4%	4/22/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$26.00 -> $30.00	Low	View details for Oppenheimer rating of Protara Therapeutics (NASDAQ:TARA) on 4/22/2024
WT WisdomTree	$9.38 +2.0%	4/22/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$12.00 -> $11.00	Low	View details for Oppenheimer rating of WisdomTree (NYSE:WT) on 4/22/2024
KYMR Kymera Therapeutics	$38.50 +0.2%	4/22/2024	Initiated by	Oppenheimer	-	Outperform	$53.00	Low	View details for Oppenheimer rating of Kymera Therapeutics (NASDAQ:KYMR) on 4/22/2024
GILD Gilead Sciences	$64.92 -0.8%	4/19/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$105.00	Low	View details for Oppenheimer rating of Gilead Sciences (NASDAQ:GILD) on 4/19/2024
NFLX Netflix	$609.47 +0.6%	4/19/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$725.00	Low	View details for Oppenheimer rating of Netflix (NASDAQ:NFLX) on 4/19/2024
SBUX Starbucks	$73.50 +1.4%	4/19/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Starbucks (NASDAQ:SBUX) on 4/19/2024
BIIB Biogen	$219.72 +0.4%	4/19/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$290.00 -> $270.00	Low	View details for Oppenheimer rating of Biogen (NASDAQ:BIIB) on 4/19/2024
EFX Equifax	$234.30 -1.0%	4/19/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$291.00 -> $272.00	Low	View details for Oppenheimer rating of Equifax (NYSE:EFX) on 4/19/2024
USB U.S. Bancorp	$41.69 +0.3%	4/18/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$55.00 -> $54.00	Low	View details for Oppenheimer rating of U.S. Bancorp (NYSE:USB) on 4/18/2024
XYL Xylem	$141.20 +0.8%	4/18/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$133.00 -> $142.00	Low	View details for Oppenheimer rating of Xylem (NYSE:XYL) on 4/18/2024
SAGE Sage Therapeutics	$12.39 -4.5%	4/18/2024	Target Lowered by	Oppenheimer	-	Market Perform -> Market Perform	$25.00 -> $17.00	Low	View details for Oppenheimer rating of Sage Therapeutics (NASDAQ:SAGE) on 4/18/2024
TRNS Transcat	$115.21 +0.7%	4/18/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$120.00 -> $125.00	Low	View details for Oppenheimer rating of Transcat (NASDAQ:TRNS) on 4/18/2024
AOS A. O. Smith	$85.58 +0.4%	4/18/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of A. O. Smith (NYSE:AOS) on 4/18/2024
WMS Advanced Drainage Systems	$168.20 +0.0%	4/18/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$172.00 -> $180.00	Low	View details for Oppenheimer rating of Advanced Drainage Systems (NYSE:WMS) on 4/18/2024
AVNT Avient	$45.12 -2.6%	4/18/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$45.00 -> $49.00	Low	View details for Oppenheimer rating of Avient (NYSE:AVNT) on 4/18/2024
CSL Carlisle Companies	$408.49 +0.7%	4/18/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$405.00 -> $412.00	Low	View details for Oppenheimer rating of Carlisle Companies (NYSE:CSL) on 4/18/2024
CARR Carrier Global	$64.31 +0.1%	4/18/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$63.00	Low	View details for Oppenheimer rating of Carrier Global (NYSE:CARR) on 4/18/2024
CAT Caterpillar	$344.50 -0.1%	4/18/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Caterpillar (NYSE:CAT) on 4/18/2024
DOV Dover	$183.75 +1.1%	4/18/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$177.00 -> $187.00	Low	View details for Oppenheimer rating of Dover (NYSE:DOV) on 4/18/2024
IEX IDEX	$222.07 +0.1%	4/18/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$245.00 -> $252.00	Low	View details for Oppenheimer rating of IDEX (NYSE:IEX) on 4/18/2024
JCI Johnson Controls International	$65.24 +1.2%	4/18/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$66.00 -> $71.00	Low	View details for Oppenheimer rating of Johnson Controls International (NYSE:JCI) on 4/18/2024
SPT Sprout Social	$26.90 -0.7%	4/18/2024	Initiated by	Oppenheimer	-	Outperform	$76.00	Low	View details for Oppenheimer rating of Sprout Social (NASDAQ:SPT) on 4/18/2024
ORCL Oracle	$117.39 -0.5%	4/18/2024	Initiated by	Oppenheimer	-	Market Perform		Low	View details for Oppenheimer rating of Oracle (NYSE:ORCL) on 4/18/2024
MWA Mueller Water Products	$18.92 +5.1%	4/18/2024	Upgraded by	Oppenheimer	-	Market Perform -> Outperform	$19.00	Low	View details for Oppenheimer rating of Mueller Water Products (NYSE:MWA) on 4/18/2024
AMRC Ameresco	$26.94 +21.1%	4/17/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Ameresco (NYSE:AMRC) on 4/17/2024
BLZE Backblaze	$9.91 +1.3%	4/17/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$11.00 -> $13.00	Low	View details for Oppenheimer rating of Backblaze (NASDAQ:BLZE) on 4/17/2024
BAC Bank of America	$37.71 -0.3%	4/17/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$46.00 -> $45.00	Low	View details for Oppenheimer rating of Bank of America (NYSE:BAC) on 4/17/2024
FSLR First Solar	$190.72 -2.0%	4/17/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$269.00	Low	View details for Oppenheimer rating of First Solar (NASDAQ:FSLR) on 4/17/2024
MS Morgan Stanley	$95.64 -0.2%	4/17/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$97.00 -> $101.00	Low	View details for Oppenheimer rating of Morgan Stanley (NYSE:MS) on 4/17/2024
PANW Palo Alto Networks	$303.01 -0.8%	4/17/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$305.00 -> $330.00	Low	View details for Oppenheimer rating of Palo Alto Networks (NASDAQ:PANW) on 4/17/2024
QMCO Quantum	$0.53 +12.2%	4/17/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Quantum (NASDAQ:QMCO) on 4/17/2024
“Crash Insurance” For Your Retirement (Ad) When it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free.
TWLO Twilio	$58.62 -7.5%	4/17/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$75.00	Low	View details for Oppenheimer rating of Twilio (NYSE:TWLO) on 4/17/2024
VIRX Viracta Therapeutics	$0.82 +0.1%	4/17/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$13.00	Low	View details for Oppenheimer rating of Viracta Therapeutics (NASDAQ:VIRX) on 4/17/2024
OBDE Blue Owl Capital Co. III	$15.53 -0.7%	4/17/2024	Initiated by	Oppenheimer	-	Outperform	$16.00	Low	View details for Oppenheimer rating of Blue Owl Capital Co. III (NYSE:OBDE) on 4/17/2024
SKIL Skillsoft	$7.14 -3.5%	4/16/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Skillsoft (NASDAQ:SKIL) on 4/16/2024
AGCO AGCO	$113.93 -2.7%	4/16/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$153.00 -> $154.00	Low	View details for Oppenheimer rating of AGCO (NYSE:AGCO) on 4/16/2024
CNHI CNH Industrial	$11.65 -2.1%	4/16/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of CNH Industrial (NYSE:CNHI) on 4/16/2024
CTVA Corteva	$56.82 -1.2%	4/16/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$62.00 -> $67.00	Low	View details for Oppenheimer rating of Corteva (NYSE:CTVA) on 4/16/2024
GS The Goldman Sachs Group	$446.95 +0.7%	4/16/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$446.00 -> $479.00	Low	View details for Oppenheimer rating of The Goldman Sachs Group (NYSE:GS) on 4/16/2024
AVTX Avalo Therapeutics	$11.73 -11.5%	4/16/2024	Upgraded by	Oppenheimer	-	Market Perform -> Outperform		Low	View details for Oppenheimer rating of Avalo Therapeutics (NASDAQ:AVTX) on 4/16/2024
C Citigroup	$62.75 +1.2%	4/15/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$88.00 -> $87.00	Low	View details for Oppenheimer rating of Citigroup (NYSE:C) on 4/15/2024
EL Estée Lauder Companies	$129.53 +0.0%	4/15/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Estée Lauder Companies (NYSE:EL) on 4/15/2024
JPM JPMorgan Chase & Co.	$195.65 +2.0%	4/15/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$219.00 -> $217.00	Low	View details for Oppenheimer rating of JPMorgan Chase & Co. (NYSE:JPM) on 4/15/2024
VRTX Vertex Pharmaceuticals	$418.82 +2.1%	4/15/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$500.00	Low	View details for Oppenheimer rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 4/15/2024
VERU Veru	$1.43 -12.3%	4/15/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$7.00 -> $5.00	Low	View details for Oppenheimer rating of Veru (NASDAQ:VERU) on 4/15/2024
WFC Wells Fargo & Company	$61.23 +1.6%	4/15/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Wells Fargo & Company (NYSE:WFC) on 4/15/2024
ZWS Zurn Elkay Water Solutions	$32.12 -0.6%	4/12/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$36.00 -> $37.00	Low	View details for Oppenheimer rating of Zurn Elkay Water Solutions (NYSE:ZWS) on 4/12/2024
RVMD Revolution Medicines	$38.31 -1.5%	4/12/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$43.00 -> $45.00	Low	View details for Oppenheimer rating of Revolution Medicines (NASDAQ:RVMD) on 4/12/2024
SKYE Skye Bioscience	$12.50 -1.8%	4/12/2024	Initiated by	Oppenheimer	-	Outperform	$25.00	Low	View details for Oppenheimer rating of Skye Bioscience (NASDAQ:SKYE) on 4/12/2024
SKYE Skye Bioscience	$12.50 -1.8%	4/12/2024	Initiated by	Oppenheimer	-	Outperform	$25.00	Low	View details for Oppenheimer rating of Skye Bioscience (NASDAQ:SKYE) on 4/12/2024
QTTB Q32 Bio	$26.28 -3.3%	4/11/2024	Initiated by	Oppenheimer	-	Outperform	$50.00	Low	View details for Oppenheimer rating of Q32 Bio (NASDAQ:QTTB) on 4/11/2024
LVRO Lavoro	$5.80 +2.3%	4/11/2024	Initiated by	Oppenheimer	-	Outperform	$11.00	Low	View details for Oppenheimer rating of Lavoro (NASDAQ:LVRO) on 4/11/2024
XPO XPO	$111.96 +1.5%	4/10/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$130.00 -> $140.00	Low	View details for Oppenheimer rating of XPO (NYSE:XPO) on 4/10/2024
KMX CarMax	$70.34 +1.6%	4/9/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$105.00	Low	View details for Oppenheimer rating of CarMax (NYSE:KMX) on 4/9/2024
CUE Cue Biopharma	$1.91 -12.4%	4/9/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$10.00	Low	View details for Oppenheimer rating of Cue Biopharma (NASDAQ:CUE) on 4/9/2024
EFX Equifax	$234.30 -1.0%	4/9/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$273.00 -> $291.00	Low	View details for Oppenheimer rating of Equifax (NYSE:EFX) on 4/9/2024
IONS Ionis Pharmaceuticals	$40.16 -1.9%	4/9/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$72.00 -> $75.00	Low	View details for Oppenheimer rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 4/9/2024
MSCI MSCI	$470.75 -0.1%	4/9/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$659.00 -> $648.00	Low	View details for Oppenheimer rating of MSCI (NYSE:MSCI) on 4/9/2024
SEIC SEI Investments	$68.57 +0.4%	4/9/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$77.00 -> $80.00	Low	View details for Oppenheimer rating of SEI Investments (NASDAQ:SEIC) on 4/9/2024
TRU TransUnion	$77.80 -1.0%	4/9/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$81.00 -> $90.00	Low	View details for Oppenheimer rating of TransUnion (NYSE:TRU) on 4/9/2024
APP AppLovin	$74.00 -4.0%	4/8/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$70.00 -> $85.00	Low	View details for Oppenheimer rating of AppLovin (NASDAQ:APP) on 4/8/2024
META Meta Platforms	$472.60 +0.9%	4/8/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$525.00 -> $585.00	Low	View details for Oppenheimer rating of Meta Platforms (NASDAQ:META) on 4/8/2024
GOOG Alphabet	$171.16 -1.1%	4/8/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$172.00 -> $185.00	Low	View details for Oppenheimer rating of Alphabet (NASDAQ:GOOG) on 4/8/2024
HCI HCI Group	$115.26 +3.3%	4/5/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$140.00	Low	View details for Oppenheimer rating of HCI Group (NYSE:HCI) on 4/5/2024
THG The Hanover Insurance Group	$135.47 +0.3%	4/5/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$150.00	Low	View details for Oppenheimer rating of The Hanover Insurance Group (NYSE:THG) on 4/5/2024
SIGI Selective Insurance Group	$99.00 -0.9%	4/5/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$120.00	Low	View details for Oppenheimer rating of Selective Insurance Group (NASDAQ:SIGI) on 4/5/2024
LULU Lululemon Athletica	$345.61 -1.2%	4/5/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$540.00 -> $445.00	Low	View details for Oppenheimer rating of Lululemon Athletica (NASDAQ:LULU) on 4/5/2024
TRV Travelers Companies	$217.34 +0.2%	4/5/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Travelers Companies (NYSE:TRV) on 4/5/2024
AXP American Express	$236.24 +0.7%	4/5/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform		Low	View details for Oppenheimer rating of American Express (NYSE:AXP) on 4/5/2024
ANGO AngioDynamics	$5.89 -4.1%	4/5/2024	Upgraded by	Oppenheimer	-	Market Perform -> Outperform	$12.00	Low	View details for Oppenheimer rating of AngioDynamics (NASDAQ:ANGO) on 4/5/2024
VRT Vertiv	$97.68 +2.9%	4/5/2024	Initiated by	Oppenheimer	-	Outperform	$96.00	Low	View details for Oppenheimer rating of Vertiv (NYSE:VRT) on 4/5/2024
GENI Genius Sports	$5.38 -0.7%	4/4/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$10.00	Low	View details for Oppenheimer rating of Genius Sports (NYSE:GENI) on 4/4/2024
ULTA Ulta Beauty	$388.48 -1.3%	4/4/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$600.00 -> $500.00	Low	View details for Oppenheimer rating of Ulta Beauty (NASDAQ:ULTA) on 4/4/2024
COIN Coinbase Global	$211.20 -1.5%	4/4/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$200.00 -> $276.00	Low	View details for Oppenheimer rating of Coinbase Global (NASDAQ:COIN) on 4/4/2024
AYI Acuity Brands	$262.27 +0.6%	4/4/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$250.00 -> $315.00	Low	View details for Oppenheimer rating of Acuity Brands (NYSE:AYI) on 4/4/2024
BMEA Biomea Fusion	$11.07 -7.8%	4/3/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$70.00	Low	View details for Oppenheimer rating of Biomea Fusion (NASDAQ:BMEA) on 4/3/2024
CMCSA Comcast	$39.05 +1.5%	4/3/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$55.00	Low	View details for Oppenheimer rating of Comcast (NASDAQ:CMCSA) on 4/3/2024
STRO Sutro Biopharma	$4.28 +0.7%	4/3/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$10.00	Low	View details for Oppenheimer rating of Sutro Biopharma (NASDAQ:STRO) on 4/3/2024
TMUS T-Mobile US	$162.83 +0.4%	4/3/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$190.00	Low	View details for Oppenheimer rating of T-Mobile US (NASDAQ:TMUS) on 4/3/2024
VZ Verizon Communications	$39.48 +0.4%	4/3/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$48.00	Low	View details for Oppenheimer rating of Verizon Communications (NYSE:VZ) on 4/3/2024
ALDX Aldeyra Therapeutics	$4.07 -2.4%	4/3/2024	Upgraded by	Oppenheimer	-	Market Perform -> Outperform	$10.00	Low	View details for Oppenheimer rating of Aldeyra Therapeutics (NASDAQ:ALDX) on 4/3/2024
Biden to Launch “FedNOW” [Move Your Money Now] (Ad) Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar... Get your free information kit NOW, before it's too late.
AIT Applied Industrial Technologies	$193.87 +0.0%	4/2/2024	Initiated by	Oppenheimer	-	Outperform	$235.00	Low	View details for Oppenheimer rating of Applied Industrial Technologies (NYSE:AIT) on 4/2/2024
MVST Microvast	$0.39 -7.3%	4/2/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$8.00 -> $4.00	Low	View details for Oppenheimer rating of Microvast (NASDAQ:MVST) on 4/2/2024
MCO Moody's	$395.94 +0.5%	4/2/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$411.00 -> $424.00	Low	View details for Oppenheimer rating of Moody’s (NYSE:MCO) on 4/2/2024
SPGI S&P Global	$429.21 +0.2%	4/2/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$480.00	Low	View details for Oppenheimer rating of S&P Global (NYSE:SPGI) on 4/2/2024
TSLA Tesla	$174.72 -1.7%	4/2/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Tesla (NASDAQ:TSLA) on 4/2/2024
JEF Jefferies Financial Group	$45.84 +0.4%	4/2/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$52.00 -> $54.00	Low	View details for Oppenheimer rating of Jefferies Financial Group (NYSE:JEF) on 4/2/2024
ACHV Achieve Life Sciences	$4.70 -0.6%	4/1/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$18.00	Low	View details for Oppenheimer rating of Achieve Life Sciences (NASDAQ:ACHV) on 4/1/2024
CALC CalciMedica	$5.60 +1.4%	4/1/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$14.00	Low	View details for Oppenheimer rating of CalciMedica (NASDAQ:CALC) on 4/1/2024
CTAS Cintas	$690.54 -0.3%	4/1/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Cintas (NASDAQ:CTAS) on 4/1/2024
DRRX DURECT	$1.02 -15.0%	4/1/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$5.00	Low	View details for Oppenheimer rating of DURECT (NASDAQ:DRRX) on 4/1/2024
KALA KALA BIO	$7.08 +2.3%	4/1/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$15.00	Low	View details for Oppenheimer rating of KALA BIO (NASDAQ:KALA) on 4/1/2024
CATX Perspective Therapeutics	1.76 -4.3%	4/1/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	1.20 -> 1.50	N/A	View details for Oppenheimer rating of Perspective Therapeutics (NYSEAMERICAN:CATX) on 4/1/2024
RH RH	$278.76 +0.1%	4/1/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of RH (NYSE:RH) on 4/1/2024
SMTC Semtech	$40.85 +2.6%	4/1/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Semtech (NASDAQ:SMTC) on 4/1/2024
ZURA Zura Bio	$4.71 +1.5%	4/1/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$17.00 -> $16.00	Low	View details for Oppenheimer rating of Zura Bio (NASDAQ:ZURA) on 4/1/2024
SG Sweetgreen	$23.25	4/1/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$17.00 -> $34.00	Low	View details for Oppenheimer rating of Sweetgreen (NYSE:SG) on 4/1/2024
BRZE Braze	$40.86 -2.9%	3/28/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$75.00	Low	View details for Oppenheimer rating of Braze (NASDAQ:BRZE) on 3/28/2024
CLRB Cellectar Biosciences	$3.20 -2.7%	3/28/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$11.00 -> $12.00	Low	View details for Oppenheimer rating of Cellectar Biosciences (NASDAQ:CLRB) on 3/28/2024
POOL Pool	$365.82 -1.8%	3/28/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$407.00 -> $436.00	Low	View details for Oppenheimer rating of Pool (NASDAQ:POOL) on 3/28/2024
RUM Rumble	$6.73 -1.8%	3/28/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Rumble (NASDAQ:RUM) on 3/28/2024
SPXC SPX Technologies	$133.92 -1.6%	3/28/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$124.00 -> $134.00	Low	View details for Oppenheimer rating of SPX Technologies (NYSE:SPXC) on 3/28/2024
CXM Sprinklr	$12.74 -0.6%	3/28/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Sprinklr (NYSE:CXM) on 3/28/2024
VRNT Verint Systems	$31.31 -0.5%	3/28/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Verint Systems (NASDAQ:VRNT) on 3/28/2024
IMVT Immunovant	$29.76 +0.6%	3/28/2024	Initiated by	Oppenheimer	-	Outperform	$50.00	Low	View details for Oppenheimer rating of Immunovant (NASDAQ:IMVT) on 3/28/2024
XERS Xeris Biopharma	$1.85 -1.6%	3/28/2024	Initiated by	Oppenheimer	-	Outperform	$5.00	Low	View details for Oppenheimer rating of Xeris Biopharma (NASDAQ:XERS) on 3/28/2024
CPRX Catalyst Pharmaceuticals	$14.72 -2.8%	3/27/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$29.00	Low	View details for Oppenheimer rating of Catalyst Pharmaceuticals (NASDAQ:CPRX) on 3/27/2024
CGTX Cognition Therapeutics	$2.00 +4.2%	3/27/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$9.00	Low	View details for Oppenheimer rating of Cognition Therapeutics (NASDAQ:CGTX) on 3/27/2024
FRGE Forge Global	$1.79 -7.7%	3/27/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$3.50	Low	View details for Oppenheimer rating of Forge Global (NYSE:FRGE) on 3/27/2024
PRGS Progress Software	$51.10 -0.5%	3/27/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$66.00	Low	View details for Oppenheimer rating of Progress Software (NASDAQ:PRGS) on 3/27/2024
STRO Sutro Biopharma	$4.28 +0.7%	3/27/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$10.00	Low	View details for Oppenheimer rating of Sutro Biopharma (NASDAQ:STRO) on 3/27/2024
WPRT Westport Fuel Systems	$5.93 -2.9%	3/27/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$19.00	Low	View details for Oppenheimer rating of Westport Fuel Systems (NASDAQ:WPRT) on 3/27/2024
ADBE Adobe	$488.10 -0.8%	3/27/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$660.00	Low	View details for Oppenheimer rating of Adobe (NASDAQ:ADBE) on 3/27/2024
UPS United Parcel Service	$147.77 +0.5%	3/27/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$153.00	Low	View details for Oppenheimer rating of United Parcel Service (NYSE:UPS) on 3/27/2024
HCI HCI Group	$115.26 +3.3%	3/27/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$140.00	Low	View details for Oppenheimer rating of HCI Group (NYSE:HCI) on 3/27/2024
VKTX Viking Therapeutics	$79.91 +0.4%	3/26/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$116.00 -> $138.00	Low	View details for Oppenheimer rating of Viking Therapeutics (NASDAQ:VKTX) on 3/26/2024
ALSN Allison Transmission	$75.82 +0.3%	3/26/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$67.00 -> $90.00	Low	View details for Oppenheimer rating of Allison Transmission (NYSE:ALSN) on 3/26/2024
A Agilent Technologies	$142.80 +1.1%	3/26/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$67.00 -> $90.00	Low	View details for Oppenheimer rating of Agilent Technologies (NYSE:A) on 3/26/2024
ADUS Addus HomeCare	$107.09 +2.4%	3/26/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$118.00	Low	View details for Oppenheimer rating of Addus HomeCare (NASDAQ:ADUS) on 3/26/2024
DYN Dyne Therapeutics	$25.69 +0.2%	3/26/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$47.00	Low	View details for Oppenheimer rating of Dyne Therapeutics (NASDAQ:DYN) on 3/26/2024
TH Target Hospitality	$11.52 +3.8%	3/25/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$12.00 -> $10.00	Low	View details for Oppenheimer rating of Target Hospitality (NASDAQ:TH) on 3/25/2024
TSLA Tesla	$174.72 -1.7%	3/25/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of Tesla (NASDAQ:TSLA) on 3/25/2024
AMPX Amprius Technologies	$2.16 +4.3%	3/22/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$15.00	Low	View details for Oppenheimer rating of Amprius Technologies (NYSE:AMPX) on 3/22/2024
DRI Darden Restaurants	$147.98 +0.6%	3/22/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$186.00 -> $182.00	Low	View details for Oppenheimer rating of Darden Restaurants (NYSE:DRI) on 3/22/2024
FDS FactSet Research Systems	$433.90 -0.4%	3/22/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of FactSet Research Systems (NYSE:FDS) on 3/22/2024
FDX FedEx	$258.01 -0.6%	3/22/2024	Reiterated by	Oppenheimer	-	Market Perform -> Market Perform		Low	View details for Oppenheimer rating of FedEx (NYSE:FDX) on 3/22/2024
SHAK Shake Shack	$102.76 -2.3%	3/22/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$108.00 -> $120.00	Low	View details for Oppenheimer rating of Shake Shack (NYSE:SHAK) on 3/22/2024
ROP Roper Technologies	$521.05 +0.2%	3/22/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$580.00 -> $650.00	Low	View details for Oppenheimer rating of Roper Technologies (NYSE:ROP) on 3/22/2024
KNF Knife River	$76.16 -3.4%	3/22/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$75.00 -> $85.00	Low	View details for Oppenheimer rating of Knife River (NYSE:KNF) on 3/22/2024
DMAC DiaMedica Therapeutics	$3.47 -5.2%	3/21/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$7.00 -> $6.00	Low	View details for Oppenheimer rating of DiaMedica Therapeutics (NASDAQ:DMAC) on 3/21/2024
TKR Timken	$89.82 -0.2%	3/21/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$97.00 -> $100.00	Low	View details for Oppenheimer rating of Timken (NYSE:TKR) on 3/21/2024
TOL Toll Brothers	$124.05 -1.9%	3/21/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$141.00 -> $157.00	Low	View details for Oppenheimer rating of Toll Brothers (NYSE:TOL) on 3/21/2024
TRVI Trevi Therapeutics	$2.64 -9.0%	3/21/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$9.00	Low	View details for Oppenheimer rating of Trevi Therapeutics (NASDAQ:TRVI) on 3/21/2024
VOR Vor Biopharma	$1.85 +5.1%	3/21/2024	Reiterated by	Oppenheimer	-	Outperform -> Outperform	$17.00 -> $15.00	Low	View details for Oppenheimer rating of Vor Biopharma (NYSE:VOR) on 3/21/2024
DKS DICK'S Sporting Goods	$196.15 -3.2%	3/20/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$190.00 -> $240.00	Low	View details for Oppenheimer rating of DICK’S Sporting Goods (NYSE:DKS) on 3/20/2024
CSL Carlisle Companies	$408.49 +0.7%	3/20/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$355.00 -> $405.00	Low	View details for Oppenheimer rating of Carlisle Companies (NYSE:CSL) on 3/20/2024
CRNX Crinetics Pharmaceuticals	$50.89 +6.8%	3/20/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$54.00 -> $55.00	Low	View details for Oppenheimer rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 3/20/2024
EQIX Equinix	$692.71 -2.7%	3/20/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$875.00 -> $950.00	Low	View details for Oppenheimer rating of Equinix (NASDAQ:EQIX) on 3/20/2024
NVDA NVIDIA	$904.12 -0.2%	3/20/2024	Target Raised by	Oppenheimer	-	Outperform -> Outperform	$850.00 -> $1,100.00	Low	View details for Oppenheimer rating of NVIDIA (NASDAQ:NVDA) on 3/20/2024
CRVS Corvus Pharmaceuticals	$1.96 +16.7%	3/20/2024	Target Lowered by	Oppenheimer	-	Outperform -> Outperform	$8.00 -> $7.00	Low	View details for Oppenheimer rating of Corvus Pharmaceuticals (NASDAQ:CRVS) on 3/20/2024
STEP StepStone Group	$37.56 -2.1%	3/20/2024	Initiated by	Oppenheimer	-	Outperform	$48.00	Low	View details for Oppenheimer rating of StepStone Group (NASDAQ:STEP) on 3/20/2024

MarketBeat Community Rating for Oppenheimer

Community Ranking:		3.1 out of 5 ( 3.1 of 5 stars)
Outperform Votes:		297 (Thanks for Voting!)
Underperform Votes:		186 (Thanks for Voting!)
Total Votes:		483

MarketBeat's community ratings are surveys of what our community members think about Oppenheimer and other research firms. Vote "Outperform" if you believe Oppenheimer's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Oppenheimer's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Ratings Reports and Tools

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Ratings for Popular Stocks:

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Oppenheimer Analyst Recommendations & Stock Picks (NYSE:OPY)

MarketBeat Community Rating for Oppenheimer

Stock Ratings Reports and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info